Facebook, Twitter Brace for Possible Election-Night Chaos
Facebook Inc. Chief Executive Officer Mark Zuckerberg, like many Americans, expects election night to be confusing. He’s worried it could also be violent.
Related Articles
Podcast: What Challenges Will Oncologists Face in 2025?
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact…
Podcast: What Challenges Will Oncologists Face in 2025?
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact…
How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer | JCO Oncology Practice
Until the early 2000s, advanced or metastatic non–small cell lung cancer (NSCLC) was treated as a single disease with all histologic subtypes treated alike with…
Expect Higher Costs for Your Health Care Benefits Next Year
Employers are predicting an increase of as much as 9 percent, on average, but are generally avoiding passing along much of that to their employees,…
9 tips for choosing a Medicare prescription drug plan
Medicare Part D is complex and can come with pitfalls — most significantly, plan terms and costs that may change every year.
Nate Pennell’s fundraising page for VeloSano
100% for the cure! Riding for my mom and all my patients living with cancer.
Nate Pennell’s fundraising page for VeloSano
100% for the cure! Riding for my mom and all my patients living with cancer.
Outcomes for Pembrolizumab Stratified by Pemetrexed Maintenance Post Pembrolizumab–Platinum–Pemetrexed Induction in Metastatic Non-Small-Cell Lung Cancer
Aim: We assessed treatment patterns and outcomes in patients with metastatic nonsquamous non-small-cell lung cancer (mNSCLC) who initiated first-line pembrolizumab–platinum–pemetrexed (induction) …
The Hidden Splendors of Cleveland’s Museums
It’s not too late to enjoy some lake weather in Cleveland, where the ice cream is fabulous and there’s never any shortage of art to…
Opinion | A $6 Billion Breakthrough or a Drop in the Bucket?
The government is finally negotiating drug prices.